{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-21-025178","form_type":"8-K","ticker":"MLAB","cik":"0000724004","company_name":"MESA LABORATORIES INC /CO/","filed_at":"2021-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:15.374210+00:00","generated_at":"2026-06-28T13:27:02.633034+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Mesa Labs Q2 FY22 revenue $35.84M (+12%), net income up 39% to $3.72M","bullets":["Revenue $35.84M (+12% YoY); operating income $4.20M (-6%); net income $3.72M (+39%); diluted EPS $0.70 vs $0.51.","Sterilization & Disinfection Control organic growth 21%; Biopharma Development organic growth 16%; Continuous Monitoring revenue record (+18%).","Instrument division revenue down 8% due to component supply and labor constraints; backlog increased.","Non-GAAP adjusted operating income $9.997M (flat YoY); adjusted diluted EPS $1.87 vs $1.91.","Completed acquisition of Agena Bioscience on Oct 20, 2021, adding Clinical Genomics capabilities."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-21-025178","json":"https://secwatch.observer/filing/0001437749-21-025178.json","markdown":"https://secwatch.observer/filing/0001437749-21-025178.md","text":"https://secwatch.observer/filing/0001437749-21-025178.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/724004/000143774921025178/0001437749-21-025178-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/724004/000143774921025178/mlab20211103_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T13:27:02.633034+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}